Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹207Cr
Seeds/Tissue Culture/Bio Technology
Rev Gr TTM
Revenue Growth TTM
36.63%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INDOUS
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | 33.1 | 15.0 | 42.6 | -12.9 | 29.1 | 40.2 | 6.6 | 111.7 | 24.5 | 39.1 | -3.2 |
| 15 | 16 | 13 | 18 | 15 | 21 | 17 | 18 | 29 | 25 | 27 | 19 |
Operating Profit Operating ProfitCr |
| 17.1 | 15.6 | 16.4 | 19.2 | 6.2 | 14.9 | 23.1 | 23.5 | 13.7 | 17.8 | 13.5 | 18.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 3 | 2 | 2 | 4 | 1 | 3 | 4 | 5 | 4 | 5 | 4 | 3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | 31.7 | 28.5 | 168.6 | -81.2 | 33.8 | 161.1 | 37.2 | 607.7 | 48.3 | -20.9 | -40.6 |
| 15.3 | 12.4 | 10.6 | 16.6 | 3.3 | 12.8 | 19.7 | 21.4 | 11.0 | 15.3 | 11.2 | 13.2 |
| 1.0 | 1.2 | 0.8 | 1.8 | 0.3 | 1.6 | 2.2 | 2.5 | 1.9 | 2.4 | 1.7 | 1.5 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 31.6 | | 19.9 | 20.2 | 12.5 | 0.8 | 24.9 | 23.4 | 18.0 | 42.6 | 13.4 |
| 15 | 19 | 23 | 27 | 32 | 36 | 35 | 43 | 52 | 62 | 85 | 99 |
Operating Profit Operating ProfitCr |
| 0.7 | 0.9 | 5.1 | 9.2 | 9.7 | 9.9 | 13.8 | 13.8 | 15.2 | 14.8 | 18.2 | 15.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 0 | 0 | 1 | 2 | 3 | 3 | 4 | 5 | 7 | 9 | 17 | 15 |
| 0 | 0 | 0 | 1 | 1 | 0 | -1 | 0 | 0 | 1 | 0 | 1 |
|
| | 146.3 | | 265.8 | 44.1 | 21.4 | 101.1 | 2.7 | 38.3 | 13.8 | 97.4 | -8.8 |
| 0.8 | 1.5 | 1.6 | 4.9 | 5.9 | 6.4 | 12.7 | 10.5 | 11.7 | 11.3 | 15.7 | 12.6 |
| 0.0 | 0.0 | 2.7 | 4.2 | 1.5 | 1.7 | 3.5 | 2.9 | 3.8 | 4.1 | 8.1 | 7.4 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 1 | 1 | 3 | 5 | 6 | 6 | 9 | 10 | 20 | 20 | 20 |
| 1 | 1 | 2 | 2 | 9 | 10 | 15 | 30 | 44 | 43 | 58 | 67 |
Current Liabilities Current LiabilitiesCr | 2 | 3 | 9 | 10 | 9 | 17 | 18 | 12 | 12 | 19 | 16 | 29 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 2 | 0 | 2 | 1 | 2 | 4 | 4 | 3 | 3 | 3 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 5 | 5 | 11 | 15 | 21 | 32 | 38 | 47 | 60 | 73 | 87 | 107 |
Non Current Assets Non Current AssetsCr | 1 | 2 | 2 | 2 | 3 | 3 | 6 | 9 | 10 | 11 | 11 | 10 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -1 | -3 | -1 | 0 | 3 | 1 | 2 | 1 |
Investing Cash Flow Investing Cash FlowCr | 0 | -3 | -1 | -2 | -5 | -7 | -3 | -1 |
Financing Cash Flow Financing Cash FlowCr | 1 | 6 | 2 | 1 | 2 | 6 | 1 | -1 |
|
Free Cash Flow Free Cash FlowCr | -1 | -4 | -1 | -2 | -1 | -1 | 0 | 1 |
| -60.9 | -151.8 | -33.3 | 4.4 | 55.5 | 7.3 | 27.0 | 8.7 |
CFO To EBITDA CFO To EBITDA% | -32.5 | -92.3 | -21.4 | 4.1 | 42.0 | 5.6 | 20.6 | 7.5 |
| Financial Year | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 51 | 31 | 20 | 62 | 213 | 445 | 295 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 24.4 | 12.3 | 3.9 | 11.8 | 29.4 | 54.0 | 18.2 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 0.8 | 0.5 | 1.2 | 3.5 | 6.1 | 2.8 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 3.7 | 1.9 | 0.9 | 1.6 | 3.9 | 7.1 | 3.8 |
| 15.0 | 0.0 | 3.9 | 2.3 | 16.4 | 9.8 | 5.6 | 10.7 | 23.9 | 42.5 | 16.4 |
Profitability Ratios Profitability Ratios |
| 19.5 | 15.6 | 17.1 | 21.4 | 37.2 | 88.8 | 99.7 | 118.0 | 96.5 | 126.9 | 98.4 |
| 0.7 | 0.9 | 5.1 | 9.2 | 9.7 | 9.9 | 13.8 | 13.8 | 15.2 | 14.8 | 18.2 |
| 0.8 | 1.5 | 1.6 | 4.9 | 5.9 | 6.4 | 12.7 | 10.5 | 11.7 | 11.3 | 15.7 |
| 9.0 | 10.8 | 13.9 | 24.7 | 16.5 | 15.3 | 16.0 | 13.0 | 13.0 | 13.4 | 19.3 |
| 5.5 | 10.6 | 11.3 | 29.3 | 15.0 | 15.4 | 23.7 | 13.5 | 13.3 | 13.1 | 20.7 |
| 2.2 | 4.3 | 3.2 | 8.4 | 8.8 | 7.3 | 11.7 | 9.4 | 10.4 | 9.8 | 16.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
**Indo US Bio-Tech Limited**, headquartered in Ahmedabad, Gujarat, is a leading Indian seed company incorporated on **February 4, 2004**. The company has evolved into a vertically integrated player in the agricultural sector, specializing in the **research, development, production, marketing, and sale of high-quality hybrid and improved seed varieties**. Over the past two decades, it has established itself as a key contributor to enhancing agricultural productivity and food security in India.
The company is **publicly listed on the BSE** and holds **DSIR (Department of Scientific & Industrial Research)** recognition for its in-house R&D center, underscoring its commitment to scientific innovation in agriculture.
---
### **Core Business Segments**
- **Primary Segment**: Agricultural Activities – Seed Production
- **Secondary Segment (as of 2021)**: Trading Activities
*(Note: Post-2021 developments emphasize focus on seed production, suggesting possible streamlining of operations.)*
---
### **Product Portfolio**
Indo US Bio-Tech offers a **diversified range of seeds** across multiple crop categories:
- **Vegetables**: Tomato, brinjal, okra, onion, cucumber, bottle gourd, chili, capsicum, sponge gourd, bitter gourd
- **Cereals**: Rice (paddy), wheat, maize, bajra (pearl millet)
- **Pulses**: Gram (chickpea), others
- **Oilseeds**: Groundnut, mustard, sesame, soybean
- **Spices**: Cumin, coriander
- **Cotton**
This broad portfolio allows the company to serve as a **one-stop solution for farmers**, enhancing customer retention and cross-selling opportunities.
---
### **Research & Development (R&D)**
The company is strongly driven by innovation and maintains a **robust in-house R&D infrastructure**, recognized by DSIR. Key highlights include:
- **R&D Facilities**:
- Research farm in **Bardoli Kanthi, Gandhinagar, Gujarat**
- **Biotechnology laboratories** including Plant Molecular Biology Lab, tissue culture facility, and genetic transformation labs
- Development of a **transgenic greenhouse** compliant with DBT biosafety guidelines
- **Seed Quality Control Laboratory** – Gujarat’s first private seed lab and India’s **second-largest seed testing lab**
- **R&D Focus Areas**:
- Development of **high-yielding, disease-resistant, pest-resistant, and climate-resilient** seed varieties
- Use of **molecular breeding, marker-assisted selection (MAS), hybridization, and transgenic technologies**
- Research on Bt crops: **Bt rice, Bt brinjal, Bt okra** (for borer resistance)
- Development of viral resistance in **okra (yellow vein mosaic), cassava (mosaic), and cotton (leaf curl virus)**
- DNA fingerprinting, germplasm characterization, and seed purity testing via PCR-based assays
- **Upcoming Infrastructure (as of 2024–2025)**:
- Construction of a new **1,050 sq. ft. biotech laboratory** equipped with:
- PCR machines, DNA sequencing, electrophoresis, freeze-dryers
- Facilities for germplasm conservation, insect bioassay, and documentation
- The new facility will support **biotech-driven crop improvement**, integrating **bioinformatics with traditional breeding**
- **Notable R&D Milestone**:
- In 2017, introduced a **high-yielding, disease-resistant chili variety** after 9 years of research and an investment of ₹60.25 lakh.
- Led by scientists: Mr. Rishi Sachan, Mr. Raghunath Kushwah, Mr. Pratik Ranoliya, and Mr. Nathubhai Jogal
---
### **Key Collaborations & MOUs (2024–2025)**
Indo US Bio-Tech has strategically partnered with **premier Indian agricultural research institutions** to co-develop and commercialize high-performing seed hybrids:
| Partner | Collaboration Focus | Product/Outcome |
|--------|----------------------|------------------|
| **Navsari Agricultural University (NAU)** | Production & distribution of rice hybrid | **GRH-2** – high-yielding, stress-resilient rice |
| **Indian Agricultural Research Institute (IARI)** | Production & marketing of maize variety | High-quality maize hybrid with enhanced yield |
| **Maharana Pratap University of Agriculture & Tech (MPUAT)** | Co-production of maize hybrid | **Pratap Hybrid Maize-3** – high-yield, resilient |
| **Directorate of Onion and Garlic Research (DOGR)** | Production of onion varieties | **Bhima Super & Bhima Red** – superior yield and quality |
| **National Horticultural Research & Development Foundation (NHRDF)** | Supply of vegetable seeds | Enhanced access to quality vegetable seeds for farmers |
These collaborations leverage public-sector research excellence to scale production and improve market reach.
---
### **Seed Processing & Infrastructure**
Indo US Bio-Tech operates **state-of-the-art processing, storage, and packaging facilities** in Gujarat, with supplementary custom units across multiple states:
- **Seed Processing**:
- Equipped with **grading, sorting, gravity separation, coating, and automatic packing machines**
- Ensures high **purity, germination rate, and phytosanitary standards**
- **Packaging**:
- Modern **automated pouch filling and sealing systems** for hygienic, efficient packaging
- **Storage & Cold Chain**:
- **Controlled temperature and humidity cold storage** (planned 24,500 sq. ft., 2,000-tonne capacity)
- Existing storage godown: **18,000 sq. ft., 1,500-tonne capacity**
- Supports seasonal and bulk storage needs
- **Proposed Expansion (2022–2025)**:
- Two new seed processing plants with combined capacity of **8,000 kg/hour**
- Focus on post-harvest management and supply chain resilience
---
### **Market Presence & Distribution Network**
- **Domestic Reach**:
- Extensive marketing network across **12+ major agricultural states**, including:
Gujarat, Maharashtra, Madhya Pradesh, Rajasthan, Uttar Pradesh, Karnataka, Punjab, Haryana, Bihar, Chhattisgarh, Jharkhand, Himachal Pradesh
- Over **2,500 distributors and dealers**
- Supply contracts with **MP, Chhattisgarh, and NAFED**
- Marketing alliance with **Gujarat State Cooperative Marketing Federation (Gujcomasol)** – the largest agro-cooperative in Gujarat
- **International Exports**:
- Supplies to **USA, Sri Lanka, Palestine, Cameroon, Kuwait, Mauritius, Oman, Myanmar, Iran, Thailand, Nicaragua, Germany, and select European countries**
- Channels: Direct exports and merchant exports
---
### **Farmer Engagement & Sustainability Initiatives**
- Conducts **field demonstrations and provides cultivation guidance** to promote adoption of improved varieties
- Implements **contract farming agreements** with attractive incentive schemes to ensure stable supply and farmer support
- Participates in **Rashtriya Krishi Vikas Yojana (RKVY)** in Gujarat for multiple years
- Focus on **sustainable agriculture** through high-efficiency, low-input seed solutions
---
### **Brand & Market Positioning**
- Strong brand equity built on **reliable performance and timely delivery**
- Flagship cotton seed varieties:
- **Indo US 955** (launched 2010)
- **Indo US 927** (launched 2011)
- Both continue to hold **significant market share**
- Products suitable for **diverse agro-climatic and stress conditions**, increasing cultivable acreage potential
---
### **Strategic Strengths**
1. **Vertical Integration**: Complete control from R&D to production and distribution
2. **DSIR-recognized R&D center** with modern biotech infrastructure
3. **Large germplasm collection** – one of the most extensive in India
4. **Strategic academic and institutional partnerships**
5. **Strong domestic distribution and proven export capability**
6. **Government supply contracts and cooperative alliances**
---
### **Challenges & Considerations**
- **Weather dependency** affecting crop yields and seed production
- **Higher cost of hybrid seeds** compared to open-pollinated varieties
- **Limited intellectual property protection** for certain products
- **Long development cycles** for new seed varieties (e.g., 9 years for chili)